27 to 28 September 2016

The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.

As always we will offer a sophisticated line-up of international speakers in four sessions focusing on the newest trends in therapeutic development. The EBCD programme also includes company presentations from innovative biotechs and of course provides conference partnering again.